High Mark Wealth Management LLC Bicycle Therapeutics PLC Transaction History
High Mark Wealth Management LLC
- $166 Million
- Q1 2025
A detailed history of High Mark Wealth Management LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, High Mark Wealth Management LLC holds 435 shares of BCYC stock, worth $3,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
435
Previous 4,435
90.19%
Holding current value
$3,662
Previous $62,000
95.16%
% of portfolio
0.0%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
102Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$91.7 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$38.4 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$29.1 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$22 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$18.5 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $250M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...